Delivery Order SPE2DB22D1017-SPE2DB25FG3DE
Award Date
5/21/25
Potential Completion Date
5/22/25
Potential Value
$4.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Entecavir 0.5 mg tablets. The contract has a total ceiling value of $10,948.32 and runs through January 31, 2025. It is a firm-fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,758.26, is for the delivery of Entecavir 0.5 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 6, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Entecavir 0.5 mg tablets. The order has a ceiling value of $6,918.52 and a completion date of August 5, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,341.22, is for the delivery of Entecavir 0.5 mg tablets. It is a firm fixed-price contract with a period of performance through May 21, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,995.03, is for the delivery of Entecavir 0.5 mg tablets. The contract is a firm-fixed price arrangement with an ultimate completion date of June 18, 2024. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the drug Entecavir 0.5 mg Tablet 30s. The contract has a ceiling value of $6,911.22 and a completion date of May 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a comprehensive range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,483.84, is for the delivery of the pharmaceutical product Entecavir 0.5 mg Tablet 30s. The contract has a firm fixed price pricing type and an ultimate completion date of May 15, 2024. This appears to be a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Entecavir 0.5mg tablets. The contract, valued at $7,808.22, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of August 18, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,791.90, is for the delivery of 4,568,142,336 units of the medication Entecavir 0.5 mg tablet in 30-count packages. The contract is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The contract has a firm fixed price, a ceiling value of $1,440.42, and a period of performance through April 30, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...